The role of sentinel lymph nodes in breast cancer
DOI:
https://doi.org/10.12775/JEHS.2022.12.06.037Keywords
sentinel lymph nodes, breast cancer, ICGAbstract
Introduction. The problem of improving early diagnosis and prognosis of breast cancer remains one of the most actual for current oncological practice. Taking into account a close correlation between the general prevalence of breast neoplasms and mortality from breast cancer, this problem is not only of professional interest, but also has medical-social and socio-economic significance.
The purpose of the study is to improve the quality of the sentinel lymph node detection in patients with breast cancer using ICG.
Material and methods. At the period 2009–2016, 400 patients with T1-T3N0M0 breast cancer were operated on. All the patients were divided into two groups using two dyes – Patent Blue and ICG. The patients after mastectomy with a sentinel lymph node biopsy had a clinical diagnosis of T2-T3N0M0 breast cancer more often.
In group I, 100 patients had the sentinel lymph node biopsy. Lymph node staining was performed using Patent Blue dye.
In group II, sentinel lymph nodes biopsy was conducted with the Patent Blue dye and another fluorescent dye — ICG, which was also injected on the affected side of the breast. After ICG dye introduction, in 15 minutes the stained green lymph nodes were detected using special equipment.
Criteria for inclusion of patients in the clinical trial:
1) breast cancer patients of any age with T1-3N0M0, I-II AB disease stage;
2) patients with clinically unaffected lymph nodes N0 after examination.
Criteria for exclusion of patients from the clinical trial:
The exceptions were T3-T4 tumors > 5 cm in diameter, or the skin and chest wall invasion, as well as palpable axillary lymph nodes, 3 or more affected lymph nodes with sentinel lymph node biopsy;
3) patients after radiation therapy.
Results. The tumor histology was performed after the node trephine biopsy. The main aims of sentinel nodes detection were staging and improving the breast cancer patients’ life quality after surgical treatment. The post-mastectomy syndrome, the main manifestation of which is swelling of the upper extremity is a big problem for patients because it affects their life quality and disturbs their usual lifestyle. The sentinel lymph node detection, in contrast to axillary lymph node dissection of I-II level, significantly minimizes all the risks of postmastectomy syndrome, in particular, impaired lymphatic drainage in the form of lymphatic edema of the upper extremity, impaired venous outflow in the form of stenoses or the axillary and/or subclavian veins occlusion, rough scars which limit the function of the extremity in the shoulder joint, and brachioplexitis.
Conclusions. The study of sentinel lymph nodes significantly improves the results of surgical treatment of breast cancer patients. Based on the clinical-laboratory and histological examinations, new data were obtained concerning the sentinel lymph node detection using two dyes, the choice of the surgical intervention volume and reduction of complications rate at the postoperative period. We found that fluorescent lymphography is highly effective, which allows to recommend it for implementation into the clinical practice. The frequency of sentinel lymph node detection in breast cancer patients is 98% in the control group, 100% – in the main group.
On the basis of the obtained results, the sentinel lymph node detection algorithm and the surgical management of patients with breast cancer was developed and implemented into practice, which allowed to reduce the number of complications with using two dyes for the sentinel lymph node detection from 19% to 2% (χ2 =15.37, p<0.001). Recurrence of breast cancer fell from 13% to 8%.
References
Canavese G, Bruzzi P, Catturich A, et al. Sentinel lymph node biopsy versus axillary dissection in node-negative early- stage breast cancer: 15-year follow-up update of a randomized clinical trial. Ann Surg Oncol 2016; 23: 2494-2500.
Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: Ten-year results of a randomized controlled study. Ann Surg 2010; 251: 595-600.
Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA 2011; 305: 569-575.
Pasquali S, Haydu LE, Scolyer RA, et al. The importance of adequate primary tumor excision margins and sentinel node biopsy in achieving optimal locoregional control for patients with thick primary melanomas. Ann Surg 2013; 258: 152-157.
Vitali GC, Trifiro G, Zonta M, et al. Lymphoscintigraphy in clinical routine practice: Reproducibility and accuracy in melanoma patients with a long-term follow-up. Eur J Surg Oncol 2014; 40: 55-60.
Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2014; 32: 1365-1383.
Pollard JZB, Graham M. Comparative analysis of 99mTc-Tilmanocept (Lymphoseek) vs. 99mTc-sulfur colloid sentinel node lymphoscintigraphy and biopsy (Abstract). J Nucl Med 2016; 57: 411.
Baker JL, Pu M, Tokin CA, et al. Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients. Ann Surg On¬col 2015; 22: 40-45.
Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): A multicentre, randomised, phase 3 trial. Lancet Oncol 2016; 17: 757-7Ç7.
Mieog JSD, Troyan SL, Hutteman M, Donohoe KJ, van der Vorst JR, Stockdale A, et al. Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol 2011; 18: 2483-2491.
Schaafsma BE, Verbeek FP, van der Vorst JR, Hutteman M, Kuppen PJ, Frangioni JV, et al. Ex vivo sentinel node mapping in colon cancer combining blue dye staining and fluorescence imaging. J Surg Res 2013; 183: 253-257.
Cahill RA, Anderson M, Wang L.M, Lindsey I, Cunningham C, Mortensen NJ. Near-infrared (NIR) laparoscopy for intraoperative lymphatic road-mapping and sentinel node identification during definitive surgical resection of early-stage colorectal neoplasia. Surg Endosc 2012; 26: 197-204.
Van der Pas MH, Ankersmit M, Stockmann HB, Silvis R, van Grieken NC, Bril H, et al. Laparoscopic sentinel lymph node identification in patients with colon carcinoma using a near-infrared dye: description of a new technique and feasibility study. J Laparoendosc Adv Surg Tech A 2013; 23: 367-371.
Yashiro M, Matsuoka T. Sentinel node navigation surgery for gastric cancer: Overview and perspective. World J Gas- trointest Surg 2015; 7: 1-9.
Can MF, Yagci G, Cetiner S. Sentinel lymph node biopsy for gastric cancer: Where do we stand? World J Gastroin- testSurg 2011; 3: 131-137.
Jo MJ, Park JY, Song JS, et al. Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer. World J Gastroenterol 2015; 21: 667-674.
Kitagawa Y, Takeuchi H, Takagi Y, et al. Sentinel node mapping for gastric cancer: A prospective multicenter trial in Japan. J Clin Oncol 2013; 31: 3704-3710.
Miyashiro I, Hiratsuka M, Sasako M, et al. High falsenegative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: Final results of the Japan Clinical Oncology Group multicenter trial JCOG0302. Gastric Cancer 2014; 17: 316-323.
Schaafsma BE, Verbeek FP, van der Vorst JR, Hut- teman M, Kuppen PJ, Frangioni JV, et al. Ex vivo sentinel node mapping in colon cancer combining blue dye staining and fluorescence imaging. J Surg Res 2013; 183: 253-257.
Broglie MA, Haile SR, Stoeckli SJ. Long-term experience in sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Ann Surg Oncol 2011; 18: 2732- 2738.
Thompson CF, St John MA, Lawson G, et al. Diagnostic value of sentinel lymph node biopsy in head and neck cancer: A meta-analysis. Eur Arch Otorhinolaryngol 2013; 270: 2115-2122.
Civantos FJ, Zitsch RP, Schuller DE, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: Results of a prospective multi-institutional trial. J Clin Oncol 2010; 28: 1395-1400.
Lam W, Alnajjar HM, La-Touche S, et al. Dynamic sentinel lymph node biopsy in patients with invasive squamous cell carcinoma of the penis: A prospective study of the longterm outcome of 500 inguinal basins assessed at a single institution. Eur Urol 2013; 63: 657-663.
Mahesan T, Coscione A, Ayres B, et al. Sentinel lymph node biopsy in renal malignancy: The past, present and future. World J Nephrol 2016; 5: 182-188.
Djajadiningrat RS, Graafland NM, van Werkhoven E, et al. Contemporary management of regional nodes in penile cancerimprovement of survival? J Urol 2014; 191: 68-73.
Grubnik VV, Nikitenko RP, Degtyarenko SP, & Grubnik VV. Тransanal endoscopic operations in rectal tumors. Klinicheskaia Khirurgiia 2019; 86(3): 15-18. doi.org/10.26779/2522-1396.2019.03.15
Van den Berg NS, Valdes-Olmos RA, van der Poel HG, et al. Sentinel lymph node biopsy for prostate cancer: A hybrid approach. J Nucl Med 2013; 54: 493-496.
Buckle T, Brouwer OR, Valdes Olmos RA, et al. Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients. J Nucl Med 2012; 53: 1026-1033.
Wit EM, Acar C, Grivas N, et al. Sentinel node procedure in prostate cancer: A systematic review to assess diagnostic accuracy. Eur Urol 2017; 71: 596-605.
Levinson KL, Escobar PF. Is sentinel lymph node dissection an appropriate standard of care for low-stage endometrial cancers? A review of the literature. Gynecol Obstet Invest 2013; 76: 139-150.
Society of Gynecologic Oncology. Clinical Practice Statement: The Role of Sentinel Lymph Node Mapping in En¬dometrial. Cancer 2015.
Cormier B, Rozenholc AT, Gotlieb W, et al. Sentinel lymph node procedure in endometrial cancer: A systematic review and proposal for standardization of future research. Gyne¬col Oncol 2015; 138: 478-485.
Wu Y, Li Z, Wu H, et al. Sentinel lymph node biopsy in cervical cancer: A meta-analysis. Mol Clin Oncol 2013; 1: 1025-1030.
Holman LL, Levenback CF, Frumovitz M. Sentinel lymph node evaluation in women with cervical cancer. J Min¬im Invasive Gynecol 2014; 21: 540-545.
Rob L, Robova H, Halaska MJ, et al. Current status of sentinel lymph node mapping in the management of cervical cancer. Expert Rev Anticancer Ther 2013; 13: 861-870.
Klapdor R, Hillemanns P, Wolber L, et al. Outcome after sentinel lymph node dissection in vulvar cancer: A subgroup analysis of the AGOCaRE-1 study. Ann Surg Oncol 2016.
Kleppe M, Brans B, Van Gorp T, et al. The detection of sentinel nodes in ovarian cancer: A feasibility study. J Nucl Med 2014; 55: 1799-1804.
Kleppe M, Kraima AC, Kruitwagen RF, et al. Understanding lymphatic drainage pathways of the ovaries to predict sites for sentinel nodes in ovarian cancer. Int J Gynecol Cancer 2015; 25: 1405-1414.
Man der Pas MH, Meijer S, Hoekstra OS, Riphagert II, de Vet HC, Knol DL, et al. Sentinel-lymph-node procedure in colon and rectal cancer: a systematic review and metaanalysis. Lancet Oncol 2011; 12: 540-550.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 R. Nikitenko, V. Kosovan, K. Vorotyntseva, E. Koichev
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 290
Number of citations: 0